Durkin Bryan T 4

What Happened
Bryan T. Durkin, a director of CME Group Inc. (CME), was granted 645 shares of Class A Common Stock on June 25, 2026. The award is valued at $225.00 per share, for a total value of $145,125. This was a grant/award (transaction code A) — not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-25 (reported on Form 4 filed 2026-06-29). The filing appears timely.
• Price per share: $225.00; total value: $145,125.
• Shares granted: 645 fully vested Class A shares.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote: The shares were issued under the CME Group Director Stock Plan as the annual equity compensation for non-employee directors and are not subject to any vesting conditions (fully vested on grant).
• Transaction type: Award/Grant (A); no 10b5-1 plan, tax-withholding, or sale noted in this report.

Context
Director grants like this are typical compensation for non-employee board members and represent an acquisition of company stock on behalf of the director. Because these shares are fully vested at grant, they do not carry future service-based vesting conditions; such awards are routine and do not, by themselves, indicate the director’s intent to buy or sell additional shares.